Neuro-Oncology Symposium Brain Tumors 2018

Friday, June 8, 2018

Please take a few minutes to complete the following questions about today's program. Your ideas and suggestions will help us to improve future programs.

Question Title

* 1. Tell us a little about yourself. I am (you may pick more than one)

In Active Treatment

Survivor

Family Member/ Caregiver

Health Care Provider

Number of years since diagnosis

Question Title

* 2. How did you hear about this conference?

Mailed Invitation

Cancer Center Website

Email Reminder

Social Media (Facebook, Twitter, etc)

Office Visit in Clinic

Word of Mouth

Other (please specify)

Question Title

* 3. Please let us know if you use any of the following of the Social Networks.

Facebook

Twitter

You Tube

Blogger

Instagram

Google+

Do not use social media

Question Title

* 4.
Program Evaluation

	Outstanding	Great	Good	Fair	Poor	N/A Viewed Via Livestream
Overall assessment of this program	Overall assessment of this program Outstanding	Overall assessment of this program Great	Overall assessment of this program Good	Overall assessment of this program Fair	Overall assessment of this program Poor	Overall assessment of this program N/A Viewed Via Livestream
Ease of registering for the conference	Ease of registering for the conference Outstanding	Ease of registering for the conference Great	Ease of registering for the conference Good	Ease of registering for the conference Fair	Ease of registering for the conference Poor	Ease of registering for the conference N/A Viewed Via Livestream
What did you think of the facility?	What did you think of the facility? Outstanding	What did you think of the facility? Great	What did you think of the facility? Good	What did you think of the facility? Fair	What did you think of the facility? Poor	What did you think of the facility? N/A Viewed Via Livestream
What did you think of the food?	What did you think of the food? Outstanding	What did you think of the food? Great	What did you think of the food? Good	What did you think of the food? Fair	What did you think of the food? Poor	What did you think of the food? N/A Viewed Via Livestream

Question Title

* 5. Please evaluate each session/speaker:

	Outstanding	Great	Good	Fair	Poor
A Prescription for the Future of American Healthcare Ezekiel J. Emanuel, MD	A Prescription for the Future of American Healthcare Ezekiel J. Emanuel, MD Outstanding	A Prescription for the Future of American Healthcare Ezekiel J. Emanuel, MD Great	A Prescription for the Future of American Healthcare Ezekiel J. Emanuel, MD Good	A Prescription for the Future of American Healthcare Ezekiel J. Emanuel, MD Fair	A Prescription for the Future of American Healthcare Ezekiel J. Emanuel, MD Poor
Comment
The New WHO Classification and the Role of Integrated Molecular Profiling in the Diagnosis of Malignant Gliomas Stefan Prokop, MD	The New WHO Classification and the Role of Integrated Molecular Profiling in the Diagnosis of Malignant Gliomas Stefan Prokop, MD Outstanding	The New WHO Classification and the Role of Integrated Molecular Profiling in the Diagnosis of Malignant Gliomas Stefan Prokop, MD Great	The New WHO Classification and the Role of Integrated Molecular Profiling in the Diagnosis of Malignant Gliomas Stefan Prokop, MD Good	The New WHO Classification and the Role of Integrated Molecular Profiling in the Diagnosis of Malignant Gliomas Stefan Prokop, MD Fair	The New WHO Classification and the Role of Integrated Molecular Profiling in the Diagnosis of Malignant Gliomas Stefan Prokop, MD Poor
Comment
Clinically Useful Next Generation Sequencing in Glioblastoma Jennifer Morrissette, PhD	Clinically Useful Next Generation Sequencing in Glioblastoma Jennifer Morrissette, PhD Outstanding	Clinically Useful Next Generation Sequencing in Glioblastoma Jennifer Morrissette, PhD Great	Clinically Useful Next Generation Sequencing in Glioblastoma Jennifer Morrissette, PhD Good	Clinically Useful Next Generation Sequencing in Glioblastoma Jennifer Morrissette, PhD Fair	Clinically Useful Next Generation Sequencing in Glioblastoma Jennifer Morrissette, PhD Poor
Comment
Advanced Neuroimaging of Brain Tumors: Radiogenomics, Predictive Biomarkers, and Response Assessment Suyash Mohan, MD, PDCC	Advanced Neuroimaging of Brain Tumors: Radiogenomics, Predictive Biomarkers, and Response Assessment Suyash Mohan, MD, PDCC Outstanding	Advanced Neuroimaging of Brain Tumors: Radiogenomics, Predictive Biomarkers, and Response Assessment Suyash Mohan, MD, PDCC Great	Advanced Neuroimaging of Brain Tumors: Radiogenomics, Predictive Biomarkers, and Response Assessment Suyash Mohan, MD, PDCC Good	Advanced Neuroimaging of Brain Tumors: Radiogenomics, Predictive Biomarkers, and Response Assessment Suyash Mohan, MD, PDCC Fair	Advanced Neuroimaging of Brain Tumors: Radiogenomics, Predictive Biomarkers, and Response Assessment Suyash Mohan, MD, PDCC Poor
Comment
Anatomic and Functional Mapping of Key Fiber Tracts to Optimize Outcomes Steven Brem, MD	Anatomic and Functional Mapping of Key Fiber Tracts to Optimize Outcomes Steven Brem, MD Outstanding	Anatomic and Functional Mapping of Key Fiber Tracts to Optimize Outcomes Steven Brem, MD Great	Anatomic and Functional Mapping of Key Fiber Tracts to Optimize Outcomes Steven Brem, MD Good	Anatomic and Functional Mapping of Key Fiber Tracts to Optimize Outcomes Steven Brem, MD Fair	Anatomic and Functional Mapping of Key Fiber Tracts to Optimize Outcomes Steven Brem, MD Poor
Comment
Laser Thermocoagulation: A New Tool for Epilepsy and Brain Tumor Surgery Timothy H. Lucas, MD, PhD	Laser Thermocoagulation: A New Tool for Epilepsy and Brain Tumor Surgery Timothy H. Lucas, MD, PhD Outstanding	Laser Thermocoagulation: A New Tool for Epilepsy and Brain Tumor Surgery Timothy H. Lucas, MD, PhD Great	Laser Thermocoagulation: A New Tool for Epilepsy and Brain Tumor Surgery Timothy H. Lucas, MD, PhD Good	Laser Thermocoagulation: A New Tool for Epilepsy and Brain Tumor Surgery Timothy H. Lucas, MD, PhD Fair	Laser Thermocoagulation: A New Tool for Epilepsy and Brain Tumor Surgery Timothy H. Lucas, MD, PhD Poor
Comment
Seeing Beyond the Visible: Fluorescent Imaging of Brain Tumors John Y.K. Lee, MD	Seeing Beyond the Visible: Fluorescent Imaging of Brain Tumors John Y.K. Lee, MD Outstanding	Seeing Beyond the Visible: Fluorescent Imaging of Brain Tumors John Y.K. Lee, MD Great	Seeing Beyond the Visible: Fluorescent Imaging of Brain Tumors John Y.K. Lee, MD Good	Seeing Beyond the Visible: Fluorescent Imaging of Brain Tumors John Y.K. Lee, MD Fair	Seeing Beyond the Visible: Fluorescent Imaging of Brain Tumors John Y.K. Lee, MD Poor
Comment
Immunotherapy for Brain Tumors – Using CAR T-Cell Platform for Glioblastoma Donald M. O’Rourke, MD	Immunotherapy for Brain Tumors – Using CAR T-Cell Platform for Glioblastoma Donald M. O’Rourke, MD Outstanding	Immunotherapy for Brain Tumors – Using CAR T-Cell Platform for Glioblastoma Donald M. O’Rourke, MD Great	Immunotherapy for Brain Tumors – Using CAR T-Cell Platform for Glioblastoma Donald M. O’Rourke, MD Good	Immunotherapy for Brain Tumors – Using CAR T-Cell Platform for Glioblastoma Donald M. O’Rourke, MD Fair	Immunotherapy for Brain Tumors – Using CAR T-Cell Platform for Glioblastoma Donald M. O’Rourke, MD Poor
Comment
The Intersection of Neurosurgery and Oncology: Tumor Margins using DESI-MS, the Neurosurgical Atlas, and Enhancing Surgical Outcomes Aaron A. Cohen-Gadol, MD	The Intersection of Neurosurgery and Oncology: Tumor Margins using DESI-MS, the Neurosurgical Atlas, and Enhancing Surgical Outcomes Aaron A. Cohen-Gadol, MD Outstanding	The Intersection of Neurosurgery and Oncology: Tumor Margins using DESI-MS, the Neurosurgical Atlas, and Enhancing Surgical Outcomes Aaron A. Cohen-Gadol, MD Great	The Intersection of Neurosurgery and Oncology: Tumor Margins using DESI-MS, the Neurosurgical Atlas, and Enhancing Surgical Outcomes Aaron A. Cohen-Gadol, MD Good	The Intersection of Neurosurgery and Oncology: Tumor Margins using DESI-MS, the Neurosurgical Atlas, and Enhancing Surgical Outcomes Aaron A. Cohen-Gadol, MD Fair	The Intersection of Neurosurgery and Oncology: Tumor Margins using DESI-MS, the Neurosurgical Atlas, and Enhancing Surgical Outcomes Aaron A. Cohen-Gadol, MD Poor
Comment
From Temozolomide to Tumor Treating Fields-Making Progress in the Management of Malignant Gliomas Roger Stupp, MD	From Temozolomide to Tumor Treating Fields-Making Progress in the Management of Malignant Gliomas Roger Stupp, MD Outstanding	From Temozolomide to Tumor Treating Fields-Making Progress in the Management of Malignant Gliomas Roger Stupp, MD Great	From Temozolomide to Tumor Treating Fields-Making Progress in the Management of Malignant Gliomas Roger Stupp, MD Good	From Temozolomide to Tumor Treating Fields-Making Progress in the Management of Malignant Gliomas Roger Stupp, MD Fair	From Temozolomide to Tumor Treating Fields-Making Progress in the Management of Malignant Gliomas Roger Stupp, MD Poor
Comment
Medical and Symptom Management of Patients with Brain Tumors Amy A. Pruitt, MD	Medical and Symptom Management of Patients with Brain Tumors Amy A. Pruitt, MD Outstanding	Medical and Symptom Management of Patients with Brain Tumors Amy A. Pruitt, MD Great	Medical and Symptom Management of Patients with Brain Tumors Amy A. Pruitt, MD Good	Medical and Symptom Management of Patients with Brain Tumors Amy A. Pruitt, MD Fair	Medical and Symptom Management of Patients with Brain Tumors Amy A. Pruitt, MD Poor
Comment
Seizure Management for Brain Tumor Survivors: Current Concepts Kathryn A. Davis, MD	Seizure Management for Brain Tumor Survivors: Current Concepts Kathryn A. Davis, MD Outstanding	Seizure Management for Brain Tumor Survivors: Current Concepts Kathryn A. Davis, MD Great	Seizure Management for Brain Tumor Survivors: Current Concepts Kathryn A. Davis, MD Good	Seizure Management for Brain Tumor Survivors: Current Concepts Kathryn A. Davis, MD Fair	Seizure Management for Brain Tumor Survivors: Current Concepts Kathryn A. Davis, MD Poor
Comment
Anti-Angiogenic Therapy and Current Clinical Trials Arati Desai, MD	Anti-Angiogenic Therapy and Current Clinical Trials Arati Desai, MD Outstanding	Anti-Angiogenic Therapy and Current Clinical Trials Arati Desai, MD Great	Anti-Angiogenic Therapy and Current Clinical Trials Arati Desai, MD Good	Anti-Angiogenic Therapy and Current Clinical Trials Arati Desai, MD Fair	Anti-Angiogenic Therapy and Current Clinical Trials Arati Desai, MD Poor
Comment
Immunotherapy and Circulating Tumor DNA in Glioblastoma Stephen Bagley, MD	Immunotherapy and Circulating Tumor DNA in Glioblastoma Stephen Bagley, MD Outstanding	Immunotherapy and Circulating Tumor DNA in Glioblastoma Stephen Bagley, MD Great	Immunotherapy and Circulating Tumor DNA in Glioblastoma Stephen Bagley, MD Good	Immunotherapy and Circulating Tumor DNA in Glioblastoma Stephen Bagley, MD Fair	Immunotherapy and Circulating Tumor DNA in Glioblastoma Stephen Bagley, MD Poor
Comment
Photons and Protons: Customizing Precision Radiation Therapy for Patients and Malignant Brain Tumors Goldie A. Kurtz, MD	Photons and Protons: Customizing Precision Radiation Therapy for Patients and Malignant Brain Tumors Goldie A. Kurtz, MD Outstanding	Photons and Protons: Customizing Precision Radiation Therapy for Patients and Malignant Brain Tumors Goldie A. Kurtz, MD Great	Photons and Protons: Customizing Precision Radiation Therapy for Patients and Malignant Brain Tumors Goldie A. Kurtz, MD Good	Photons and Protons: Customizing Precision Radiation Therapy for Patients and Malignant Brain Tumors Goldie A. Kurtz, MD Fair	Photons and Protons: Customizing Precision Radiation Therapy for Patients and Malignant Brain Tumors Goldie A. Kurtz, MD Poor
Comment
Targeted Therapy for Brain Metastases (Melanoma, Breast and Lung Cancer): Principles and Progress Tara C. Mitchell, MD	Targeted Therapy for Brain Metastases (Melanoma, Breast and Lung Cancer): Principles and Progress Tara C. Mitchell, MD Outstanding	Targeted Therapy for Brain Metastases (Melanoma, Breast and Lung Cancer): Principles and Progress Tara C. Mitchell, MD Great	Targeted Therapy for Brain Metastases (Melanoma, Breast and Lung Cancer): Principles and Progress Tara C. Mitchell, MD Good	Targeted Therapy for Brain Metastases (Melanoma, Breast and Lung Cancer): Principles and Progress Tara C. Mitchell, MD Fair	Targeted Therapy for Brain Metastases (Melanoma, Breast and Lung Cancer): Principles and Progress Tara C. Mitchell, MD Poor
Comment
Stories of Patient Survivors: Navigating the Health Care System, Finding Information, Clinical Trials, Innovation, and Hope Arbena Merolli, MSW Eleanor Miller, MSN, RN, OCN, CBCN Karen Albright, MSN, CRNP	Stories of Patient Survivors: Navigating the Health Care System, Finding Information, Clinical Trials, Innovation, and Hope Arbena Merolli, MSW Eleanor Miller, MSN, RN, OCN, CBCN Karen Albright, MSN, CRNP Outstanding	Stories of Patient Survivors: Navigating the Health Care System, Finding Information, Clinical Trials, Innovation, and Hope Arbena Merolli, MSW Eleanor Miller, MSN, RN, OCN, CBCN Karen Albright, MSN, CRNP Great	Stories of Patient Survivors: Navigating the Health Care System, Finding Information, Clinical Trials, Innovation, and Hope Arbena Merolli, MSW Eleanor Miller, MSN, RN, OCN, CBCN Karen Albright, MSN, CRNP Good	Stories of Patient Survivors: Navigating the Health Care System, Finding Information, Clinical Trials, Innovation, and Hope Arbena Merolli, MSW Eleanor Miller, MSN, RN, OCN, CBCN Karen Albright, MSN, CRNP Fair	Stories of Patient Survivors: Navigating the Health Care System, Finding Information, Clinical Trials, Innovation, and Hope Arbena Merolli, MSW Eleanor Miller, MSN, RN, OCN, CBCN Karen Albright, MSN, CRNP Poor
Comment

Question Title

* 6. How would you rate the conference handout materials/website?

Excellent

Very Good

Fair

Poor

Question Title

* 7. How helpful was this conference to your personal situation and/or professional practice?

Very Helpful

Helpful

Somewhat Helpful

Not Helpful

N/A

Question Title

* 8. Was this conference what you expected?

Yes

If no, please explain.

Question Title

* 9. Based on the information you received today, please evaluate your level of confidence 1 (no confidence) to 4 (high level of confidence)

	No Confidence	Little Confidence	Confidence	High Level of Confidence
I feel confident to actively participate, with my care team, in my care	I feel confident to actively participate, with my care team, in my care No Confidence	I feel confident to actively participate, with my care team, in my care Little Confidence	I feel confident to actively participate, with my care team, in my care Confidence	I feel confident to actively participate, with my care team, in my care High Level of Confidence
I feel confident to make ongoing treatment decisions with my care team	I feel confident to make ongoing treatment decisions with my care team No Confidence	I feel confident to make ongoing treatment decisions with my care team Little Confidence	I feel confident to make ongoing treatment decisions with my care team Confidence	I feel confident to make ongoing treatment decisions with my care team High Level of Confidence
I feel confident with the language of Neuro-Oncology Care	I feel confident with the language of Neuro-Oncology Care No Confidence	I feel confident with the language of Neuro-Oncology Care Little Confidence	I feel confident with the language of Neuro-Oncology Care Confidence	I feel confident with the language of Neuro-Oncology Care High Level of Confidence
I feel confident in describing strategies to cope with emotions related to cancer	I feel confident in describing strategies to cope with emotions related to cancer No Confidence	I feel confident in describing strategies to cope with emotions related to cancer Little Confidence	I feel confident in describing strategies to cope with emotions related to cancer Confidence	I feel confident in describing strategies to cope with emotions related to cancer High Level of Confidence
I feel confident in describing how to manage symptoms of treatment	I feel confident in describing how to manage symptoms of treatment No Confidence	I feel confident in describing how to manage symptoms of treatment Little Confidence	I feel confident in describing how to manage symptoms of treatment Confidence	I feel confident in describing how to manage symptoms of treatment High Level of Confidence
I feel confident in describing when to call my doctor/nurse or other member of my health care team	I feel confident in describing when to call my doctor/nurse or other member of my health care team No Confidence	I feel confident in describing when to call my doctor/nurse or other member of my health care team Little Confidence	I feel confident in describing when to call my doctor/nurse or other member of my health care team Confidence	I feel confident in describing when to call my doctor/nurse or other member of my health care team High Level of Confidence

Question Title

* 10. What part of the program was most helpful to you?

Question Title

* 11. Please make any additional comments or suggestions on how this program could be improved.

Question Title

* 12. What topics would be of interest to you at future events?

Question Title

* 13. Please check your preference for location of future conferences from the following locations:

	Least Preferred	Neutral	Most Preferred
City Line Area	City Line Area Least Preferred	City Line Area Neutral	City Line Area Most Preferred
Penn Campus (Perelman, Smilow, etc)	Penn Campus (Perelman, Smilow, etc) Least Preferred	Penn Campus (Perelman, Smilow, etc) Neutral	Penn Campus (Perelman, Smilow, etc) Most Preferred
Airport Area	Airport Area Least Preferred	Airport Area Neutral	Airport Area Most Preferred
Penn's Landing	Penn's Landing Least Preferred	Penn's Landing Neutral	Penn's Landing Most Preferred
Center City	Center City Least Preferred	Center City Neutral	Center City Most Preferred
North Philadelphia, Germantown, Mt Airy	North Philadelphia, Germantown, Mt Airy Least Preferred	North Philadelphia, Germantown, Mt Airy Neutral	North Philadelphia, Germantown, Mt Airy Most Preferred
South, West, Southwest Philadelphia	South, West, Southwest Philadelphia Least Preferred	South, West, Southwest Philadelphia Neutral	South, West, Southwest Philadelphia Most Preferred
Web livestream	Web livestream Least Preferred	Web livestream Neutral	Web livestream Most Preferred

Question Title

* 1. Tell us a little about yourself. I am (you may pick more than one)

Question Title

* 2. How did you hear about this conference?

Question Title

* 3. Please let us know if you use any of the following of the Social Networks.

Question Title

* 4. Program Evaluation

Question Title

* 5. Please evaluate each session/speaker:

Question Title

* 6. How would you rate the conference handout materials/website?

Question Title

* 7. How helpful was this conference to your personal situation and/or professional practice?

Question Title

* 8. Was this conference what you expected?

Question Title

* 9. Based on the information you received today, please evaluate your level of confidence 1 (no confidence) to 4 (high level of confidence)

Question Title

* 10. What part of the program was most helpful to you?

Question Title

* 11. Please make any additional comments or suggestions on how this program could be improved.

Question Title

* 12. What topics would be of interest to you at future events?

Question Title

* 13. Please check your preference for location of future conferences from the following locations:

* 4.
Program Evaluation